Home

tiltakozás láva Mesterséges interferon kappa beta Közvetít Halloween Vezetéknév

Frontiers | Evasion of interferon-mediated immune response by arteriviruses
Frontiers | Evasion of interferon-mediated immune response by arteriviruses

Cells | Free Full-Text | Signaling Pathways of Type I and Type III  Interferons and Targeted Therapies in Systemic Lupus Erythematosus
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus

Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science

Frontiers | The Role of Interferons in Inflammation and Inflammasome  Activation
Frontiers | The Role of Interferons in Inflammation and Inflammasome Activation

Interferons | Bio-Techne
Interferons | Bio-Techne

Interferons Research Area: R&D Systems
Interferons Research Area: R&D Systems

Early and delayed events in interferon signaling. The recognition of... |  Download Scientific Diagram
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram

An Atomic Model of the Interferon-β Enhanceosome: Cell
An Atomic Model of the Interferon-β Enhanceosome: Cell

Interferon pathway in SLE: one key to unlocking the mystery of the disease  | Lupus Science & Medicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine

Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... |  Download Scientific Diagram
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram

The Overview of Interferon-CUSABIO
The Overview of Interferon-CUSABIO

How cancer cells make and respond to interferon-I: Trends in Cancer
How cancer cells make and respond to interferon-I: Trends in Cancer

GeneCopoeia: IFN alpha signaling pathway
GeneCopoeia: IFN alpha signaling pathway

Frontiers | Shared and Unique Features of Human Interferon-Beta and  Interferon-Alpha Subtypes
Frontiers | Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and  Heterogeneity across Diseases | PLOS ONE
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases | PLOS ONE

Frontiers | Importance of Type I and III Interferons at Respiratory and  Intestinal Barrier Surfaces
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces

Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR |  Life Science | Bio-Rad
Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR | Life Science | Bio-Rad

Interferon target-gene expression and epigenomic signatures in health and  disease | Nature Immunology
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology

A clinical pilot study on the safety and efficacy of aerosol inhalation  treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 -  eClinicalMedicine
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine

IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and  Therapeutic Potential of the Interferon Pathway in Systemic Lupus  Erythematosus and Other Autoimmune Diseases
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases

Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN)  signaling pathway | SpringerLink
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink

An open-label, randomized trial of the combination of IFN-κ plus TFF2 with  standard care in the treatment of patients with moderate COVID-19 -  eClinicalMedicine
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine

Interferon pathway in SLE: one key to unlocking the mystery of the disease  | Lupus Science & Medicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine

Interferons Research Area: R&D Systems
Interferons Research Area: R&D Systems

How cancer cells make and respond to interferon-I: Trends in Cancer
How cancer cells make and respond to interferon-I: Trends in Cancer